Tandem Diabetes Care
TNDM
46 hedge funds and large institutions have $28M invested in Tandem Diabetes Care in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 15 reducing their positions, and 24 closing their positions.
90% more capital invested
Capital invested by funds: $14.7M → $28M (+$13.3M)
0.53% less ownership
Funds ownership: 3.69% → 3.16% (-0.53%)
27% less funds holding
Funds holding: 63 → 46 (-17)
33% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 15
71% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$154K |
| 2 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
+$115K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$107K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$102K |
| 5 |
VF
Virtu Financial
New York
|
+$63K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$579K |
| 2 |
PC
Paulson & Co
New York
|
-$400K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$314K |
| 4 |
FPC
Falcon Point Capital
San Francisco,
California
|
-$209K |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
-$187K |
TNDM Hedge Fund Activity: Q3 2017 in Review
46 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q3 2017, worth a combined $28M — up 90% from $14.7M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of TNDM and 7 opened new positions — a net loss of 17 holders — while 15 trimmed existing stakes and 10 added.
The largest buyer was BlackRock, adding an estimated $154K. The largest seller was DAFNA Capital Management, exiting entirely with an estimated $579K sold.
- 46 institutional investors held Tandem Diabetes Care (TNDM) as of Q3 2017, down from 63 in Q2 2017.
- Funds reported $28M of Tandem Diabetes Care stock for Q3 2017, up 90% quarter-over-quarter.
- 7 funds opened new Tandem Diabetes Care positions in Q3 2017 and 24 closed out, a net change of -17 holders.
- The largest Tandem Diabetes Care buyer in Q3 2017 was BlackRock, an estimated $154K added.
- The largest Tandem Diabetes Care seller in Q3 2017 was DAFNA Capital Management, an estimated $579K sold.
Based on aggregated 13F filings for Q3 2017.